Literature DB >> 20646926

The GABA(A) receptor as a target for photochromic molecules.

Mariel Feliciano1, Devaiah Vytla, Kathryne A Medeiros, James J Chambers.   

Abstract

Photochromic ligands, molecules that can be induced to change their physical properties through applied light, are currently the topic of much chemical biology research. This specialized class of small organic structures are, surprisingly to many, fairly common in nature. At the core of a number of natural biological processes lies a small molecule that changes shape or some other measurable property in response to light absorption. For instance, conformational changes invoked by reversible photoisomerization of a retinoid small molecule found in the photoreceptors of the human eye leads to vision. In plants, photoisomerization of a cinnamate moiety leads to altered gene expression. The photosensitive molecule can be viewed simply as a nanosensor of light, much like a photosensitive electrical component might be added to a circuit to sense day versus night to turn an electrical circuit on or off. Synthetic organic chemists and chemical biologists have been, for at least the last 15years, trying to either mimic or exploit the native photochromism found in nature. Here, we describe the design process to develop a photochromic molecule to be used in neurobiology.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20646926      PMCID: PMC4233676          DOI: 10.1016/j.bmc.2010.05.056

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  32 in total

1.  Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach.

Authors:  Q Huang; X He; C Ma; R Liu; S Yu; C A Dayer; G R Wenger; R McKernan; J M Cook
Journal:  J Med Chem       Date:  2000-01-13       Impact factor: 7.446

Review 2.  GABA(A) receptor ligands and their therapeutic potentials.

Authors:  Bente Frølund; Bjarke Ebert; Uffe Kristiansen; Tommy Liljefors; Povl Krogsgaard-Larsen
Journal:  Curr Top Med Chem       Date:  2002-08       Impact factor: 3.295

Review 3.  AMPA receptor trafficking at excitatory synapses.

Authors:  David S Bredt; Roger A Nicoll
Journal:  Neuron       Date:  2003-10-09       Impact factor: 17.173

4.  Light-activated drug confirms a mechanism of ion channel blockade.

Authors:  H A Lester; M E Krouse; M M Nass; N H Wassermann; B F Erlanger
Journal:  Nature       Date:  1979-08-09       Impact factor: 49.962

5.  Alpha5GABAA receptor activity sets the threshold for long-term potentiation and constrains hippocampus-dependent memory.

Authors:  Loren J Martin; Agnieszka A Zurek; John F MacDonald; John C Roder; Michael F Jackson; Beverley A Orser
Journal:  J Neurosci       Date:  2010-04-14       Impact factor: 6.167

6.  GABA(A) receptor binding and localization in the tiger salamander retina.

Authors:  H Wang; K M Standifer; D M Sherry
Journal:  Vis Neurosci       Date:  2000 Jan-Feb       Impact factor: 3.241

7.  Lateral mobility and specific binding to GABA(A) receptors on hippocampal neurons monitored by fluorescence correlation spectroscopy.

Authors:  Oliver Meissner; Hanns Häberlein
Journal:  Biochemistry       Date:  2003-02-18       Impact factor: 3.162

8.  Kinetics of tethering quaternary ammonium compounds to K(+) channels.

Authors:  Robert O Blaustein
Journal:  J Gen Physiol       Date:  2002-08       Impact factor: 4.086

Review 9.  Tethering: fragment-based drug discovery.

Authors:  Daniel A Erlanson; James A Wells; Andrew C Braisted
Journal:  Annu Rev Biophys Biomol Struct       Date:  2004

Review 10.  Phosphoinositide signaling; from affinity probes to pharmaceutical targets.

Authors:  Glenn D Prestwich
Journal:  Chem Biol       Date:  2004-05
View more
  1 in total

Review 1.  Synapses in the spotlight with synthetic optogenetics.

Authors:  Shai Berlin; Ehud Y Isacoff
Journal:  EMBO Rep       Date:  2017-04-10       Impact factor: 8.807

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.